| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $640K | -97.5% |
| Cost of Revenue | $433K | -98.3% |
| Gross Profit | $207K | -56.0% |
| R&D Expense | $113K | -96.7% |
| SG&A Expense | $2.1M | -56.7% |
| Operating Income | -$4.2M | +75.4% |
| Interest Expense | $386K | +0.0% |
| Pre-tax Income | -$4.2M | +75.9% |
| Income Tax | $11K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30K | -95.7% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $10.0M | +0.0% |
| Current Assets | $165K | -98.6% |
| Total Assets | $307K | -97.5% |
| Current Liabilities | $437K | -96.4% |
| Stockholders' Equity | -$130K | -212.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.8M | -177.8% |
| Capital Expenditures | $162K | +0.0% |
| Investing Cash Flow | $12K | +103.0% |
| Financing Cash Flow | $3.1M | +164.3% |
| Free Cash Flow | -$3.9M | -183.9% |
| -73.7% |
| Net Income | -$4.2M | +76.0% |
| EPS (Basic) | -$1.34 | +85.2% |
| EPS (Diluted) | -$1.34 | +85.2% |